Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons

This study has been completed.
Sponsor:
Collaborators:
GlaxoSmithKline
National Institutes of Health (NIH)
Information provided by:
University of Washington
ClinicalTrials.gov Identifier:
NCT00161434
First received: September 8, 2005
Last updated: December 29, 2007
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2006
  Primary Completion Date: June 2006 (Final data collection date for primary outcome measure)